Principal Financial Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,654
| Closed | -$21.9K | – | 2365 |
|
|
2024
Q1 | $21.9K | Sell |
17,654
-1,765
| -9% | -$2.19K | ﹤0.01% | 2401 |
|
|
2023
Q4 | $20.4K | Buy |
19,419
+654
| +3% | +$687 | ﹤0.01% | 2384 |
|
|
2023
Q3 | $129K | Sell |
18,765
-368
| -2% | -$2.52K | ﹤0.01% | 2242 |
|
|
2023
Q2 | $198K | Buy |
19,133
+2,200
| +13% | +$22.8K | ﹤0.01% | 2186 |
|
|
2023
Q1 | $137K | Sell |
16,933
-1,275
| -7% | -$10.3K | ﹤0.01% | 2243 |
|
|
2022
Q4 | $287K | Buy |
18,208
+1,811
| +11% | +$28.5K | ﹤0.01% | 2112 |
|
|
2022
Q3 | $259K | Buy |
16,397
+240
| +1% | +$3.79K | ﹤0.01% | 2128 |
|
|
2022
Q2 | $226K | Sell |
16,157
-16,096
| -50% | -$225K | ﹤0.01% | 2263 |
|
|
2022
Q1 | $556K | Sell |
32,253
-13,152
| -29% | -$227K | ﹤0.01% | 2092 |
|
|
2021
Q4 | $660K | Sell |
45,405
-7,590
| -14% | -$110K | ﹤0.01% | 2065 |
|
|
2021
Q3 | $954K | Buy |
52,995
+8,799
| +20% | +$158K | ﹤0.01% | 2015 |
|
|
2021
Q2 | $776K | Buy |
+44,196
| New | +$776K | ﹤0.01% | 2105 |
|